Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. 15 wrz 2022 · Complete thrombus resolution was achieved in 62.3% (n=99) at a median of 103 days (interquartile range, 32–392 days). 17 Recurrence of thrombus or an increase in LV thrombus area was observed in 14.5% (n=23), a finding associated with poor adherence, prothrombotic conditions, and increased mortality. 17.

    • View EPUB

      (r·=™Z¢ÔþÛôn =Yj > h~}¤ÄŽ@ ]|Ÿög š×/|ë@¾l÷ †u¢ÚsÅCÈù?\yÓ©b...

    • Linda S. Williams

      These results were statistically significant compared with...

    • PDF/Epub

      PK u!3Yoa«, mimetypeapplication/epub+zipPK u!3Y...

    • Trial

      Background—The Randomized Evaluation of Long-term...

  2. Left ventricular (LV) thrombus is a feared complication of LV dysfunction associated with high rates of systemic embolism, morbidity, and mortality. Traditionally, LV thrombus has been associated with acute myocardial infarction (MI).

  3. 1 maj 2023 · Echocardiographic outcomes evaluated included resolution of thrombus size and time to complete thrombus resolution. Clinical outcomes included mortality, thromboembolic complications, and bleeding complications.

  4. LV thrombus resolution after 6 months was seen in 92 (79.3%) patients in the warfarin group and 32 (66.6%) patients in the NOAC group (p=0.08). Bleeding rates were similar amongst both groups (8% vs. 10%, p=0.768).

  5. Abstract. Left ventricular thrombus (LVT) is a serious complication of acute myocardial infarction (MI) and also non-ischemic cardiomyopathies. We performed a narrative literature review, manual-search of reference lists of included articles and relevant reviews.

  6. Here we propose an algorithmic approach to the diagnosis and management of left ventricular (LV) thrombus following acute myocardial infarction (AMI) that begins with transthoracic echocardiography (TTE) with contrast within 24 hours of index myocardial infarction (MI).

  7. Pooled data from these 21 studies included 3057 patients with LV thrombus, of whom 824 were treated with DOAC and 2233 treated with VKA. The median follow-up time (according to data from 19 studies) was 12 months (interquartile range, 6–24 months).